Royalty Pharma (RPRX) total assets

Total assets · fiscal 2025
$19.62B

Royalty Pharma (RPRX) had total assets of $19.62B at the end of fiscal 2025 (December 31, 2025). That is 7.7% higher than the $18.22B of fiscal 2024. Figures as of 18 Nov 2026, 04:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$19.62B
Change on fiscal 2024
+7.7%
Growth, 5 years
+4.1% a year
Highest on record
$19.62Bfiscal 2025
Lowest on record
$12.45Bfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Royalty Pharma total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 4.1% a year. Across the 7 fiscal years on record (2019–2025), the highest was $19.62B in fiscal 2025 and the lowest $12.45B in fiscal 2019.

History · 7 fiscal years

Total assets by fiscal year

Royalty Pharma total assets, year by year

Royalty Pharma (RPRX) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$19.62B 7.7% up
2024$18.22B 11.2% up
2023$16.38B 2.6% down
2022$16.81B 4.0% down
2021$17.52B 9.3% up
2020$16.02B 28.7% up
2019$12.45B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Royalty Pharma and comparable companies
CompanyTotal assetsFiscal year
IQVIA Holdings IQV$29.94B2025
Revolution Medicines RVMD$2.35B2025
Royalty Pharma RPRX$19.62B2025
Biogen BIIB$29.44B2025
GE HealthCare Technologies GEHC$36.91B2025
Alcon ALC$31.56B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RPRX

Royalty Pharma, figure by figure

Royalty Pharma (RPRX) overview: price, valuation and scorecardAll health care companies by market value

Royalty Pharma total assets: questions and answers

How large are Royalty Pharma's total assets?

Royalty Pharma (RPRX) had total assets of $19.62B at the end of fiscal 2025 (December 31, 2025). That is 7.7% higher than the $18.22B of fiscal 2024.

What is the growth rate of Royalty Pharma's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 4.1% a year.

What are the highest and lowest total assets figures on record for Royalty Pharma?

Across the 7 fiscal years on record (2019–2025), the highest was $19.62B in fiscal 2025 and the lowest $12.45B in fiscal 2019.

How is Royalty Pharma's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Royalty Pharma (RPRX) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/RPRX/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.